FilingsTodayLion Chemtech
At a glance
Lion Chemtech filed 15 disclosures in the last 12 months.
Revenue for 2025 was ₩130B, down 8.1% on 2024. Operating margin was 8.7% against 6.6% a year earlier. Debt was 20% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩78.6B and operating profit of ₩9.4B.
The 2025 annual report lists 151 employees with an average tenure of 8.2 years and average pay of ₩52.7M, #1331 of 1,829 listed companies by average pay. Its 10 directors and auditors were paid ₩94M each on average. It paid ₩100 per common share in cash dividends, against ₩100 a year earlier (+0%). (주)태경비케이 and related parties held 55.58% at year end.
From the 2025 annual report
Staff: 151 (130 men, 21 women), of whom 9 on fixed-term contracts. Total pay for the year: ₩7.9B. Directors and auditors: 10, paid ₩937M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩100 | ₩100 | ₩100 |
| Payout ratio | 41.5% | 17.4% | 50.6% |
| Yield (as filed) | 4.46% | 3.52% | 3.00% |
| Total cash dividends | ₩3.5B | ₩1.5B | ₩3.6B |
Largest shareholder
(주)태경비케이 holds 34.26%; with 1 related party the group holds 55.58% of common shares at year end.
Individuals paid ₩500M or more
| 박희원 - | ₩6.5B |
| 박서영 - | ₩1B |
| 최기섭 연구고문 | ₩694M |
Auditor: 신우회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
No key filings in the last 12 months.
Other filings
Links open the original filing on DART, in Korean.